An important question in xenotransplantation is whether an allotransplant can safely be carried out in a patient who has become sensitized to a pig xenograft. To answer this question, we have searched the literature. We primarily limited our review to the clinically relevant pig-to-non-human primate (NHP) model and found five studies that
| INTRODUC TI ON
There is a continuing shortage of organs from deceased human donors for the purpose of transplantation into patients with end-stage organ failure. 1 Xenotransplantation could provide an alternative source of organs. Recently, there has been substantial progress in overcoming the barriers to xenotransplantation, especially through the transplantation of organs from genetically engineered pigs combined with effective immunosuppressive therapy. We primarily limited our search to studies directly relevant to pig organ or cell transplantation in humans, which largely related to studies in pig-to-non-human primate (NHP) (discordant) models.
However, some other experimental studies, including those relating explored this topic. No NHP that had received a pig graft developed antibodies to alloantigens, and in vitro studies indicated no increased humoral and/or cellular alloreactivity. We carried out a small in vitro study ourselves that confirmed this conclusion. There have been three experiments in which patients undergoing dialysis were exposed to wild-type pig kidneys and three clinical studies related to bridging a patient in hepatic failure to liver allotransplantation. Despite the development of anti-pig antibodies, all subsequent organ (kidney or liver) allografts were successful (except possibly in one case). In addition, pig fetal islets were transplanted into patients with kidney allografts; there was no increase in panel-reactive alloantibodies and the kidney grafts continued to function satisfactorily. In conclusion, the limited data suggest that, after sensitization to pig antigens, there is no evidence of antibody-mediated or accelerated cellular rejection of a subsequent allograft.
K E Y W O R D S
antibodies, cross-reacting, clinical trial, immune response, human, non-human primate, pig, sensitization, xenotransplantation to xenotransplantation between closely related NHP (concordant) models, will be briefly summarized. We also searched for experience in clinical xenotransplantation.
| E XPERIMENTAL S ECONDARY ALLOTR ANS PL ANTATION AF TER XENO -S ENS ITIZ ATION IN DISCORDANT MODEL S
"Discordant" relates to models in which transplantation is carried out between widely disparate species where hyperacute rejection usually results, for example, wild-type (WT, i.e, genetically unmodified) pig-to-NHP. 3 We identified only five relevant reports (Table 1) .
Within these reports were three in which in vitro studies were carried out after in vivo exposure to pig antigens and three in which both in vitro studies and additional allotransplantation were carried out. In addition, however, we have carried out a new in vitro study which we report below.
Ye et al 4 were the first (in 1995) to investigate this topic. In immunosuppressed baboons that were sensitized by WT pig heart transplants (n = 2, with the grafts undergoing hyperacute rejection)
or by pig erythrocytes (n = 1), subsequent baboon liver allografts survived without evidence of antibody-mediated or accelerated cellular rejection. No baboon developed antibodies that cross-reacted with alloantigens.
This group also tested sera from baboons that had rejected a WT pig liver (n = 2) or heart (n = 1) graft against a panel of baboon lymphocytes (n = 6). No cytotoxicity of the baboon lymphocytes was documented, supporting a conclusion that sensitization to pig antigens did not result in allosensitization. in vivo exposure to a pig heart or pig red blood cells; (iii) baboons sensitized to Gal+non-Gal antigens (n = 2) by prior in vivo exposure to a pig heart or pig PBMC; and (iv) baboons sensitized to alloantigens (n = 2). In an antibody assay, baboon serum containing antipig xenoantibodies was cultured with baboon or pig PBMCs. There was no cross-reactivity between xenoantibodies and alloantigens.
A complement-dependent cytotoxicity assay indicated no killing of baboon PBMC, and mixed lymphocyte reaction suggested no increased T-cell proliferative response to alloantigens. Although the study was limited, it produced no evidence that a previous pig xenograft would be detrimental to a secondary allograft. purified" HLA. There was no detectable increase in anti-HLA IgG antibodies after pig kidney transplantation.
In a WT pig-to-Chinese rhesus monkey decellularized corneal xenotransplantation model, porcine corneal lamellar (anterior partial thickness) xenografts were followed by full-thickness corneal allografts (n = 5). 7 All recipients received immunosuppressive therapy (topical prednisolone acetate, subconjunctival dexamethasone, systemic methylprednisolone). Only one of five pig corneal grafts was rejected, with four grafts surviving for 7-13 months, at which time the monkey received an allograft. On in vitro assays, there was no evidence that any humoral or cellular immune response to the xenograft adversely affected the survival of the allograft. However, the fact that 4 of the 5 xenografts were not rejected suggests that no xenoreactive antibodies developed, thus reducing the likelihood of an immune response to the allograft. Furthermore, there are differences in the mechanism of rejection between an organ and a cornea.
In a pig-to-baboon skin xenotransplantation model, Albritton et al 8 studied four groups: (i) a primary baboon skin allograft (survival for 12-13 days) followed by a secondary skin graft from an α1,3-galactosyltransferase gene-knockout (GTKO) pig (survival for 10-13 days); (ii) a primary GTKO pig skin xenograft (survival for 11-13 days)
followed by a secondary baboon skin allograft (survival for 10-14 days);
(iii) a primary GTKO pig xenograft (survival for 7-11 days) followed by a secondary GTKO pig xenograft (survival for 1 day); and (iv) a primary allograft (survival for 7-11 days) followed by a secondary allograft (survival for 4 days). These results suggested that primary allograft or xenograft rejection did not accelerate the rejection of, respectively, a subsequent xenograft or allograft. However, initial sensitization to xenoantigens or alloantigens accelerated rejection of, respectively, a subsequent xenograft or allograft. A primary skin allograft was associated with the production of anti-allogeneic antibody, but not anti-xenogeneic antibody, and a primary xenograft did not induce antibodies directed to an allograft. In the highly immunogenic skin transplant model, therefore, there was no cross-reactivity between xenoantibodies and alloantigens or between alloantibodies and xenoantigens.
In order to add to the experience on this topic, we have carried naïve baboons (n = 8), (ii) baboons exposed to pig antigens (in the form of organs or artery patch graft) that had not become sensitized (n = 4) and (iii) baboons exposed to pig antigens that had become sensitized (n = 4). Although there was minimal antibody binding of naïve and non-sensitized sera to GTKO/CD46 pig PBMCs, there was significant binding of sensitized serum (both IgM and IgG) to these cells (P < .05) (Figure 1 ). In contrast, there was no significant binding of any baboon serum to baboon PBMC. This small study strengthens the conclusion that prior sensitization to a pig xenograft would not be detrimental to a subsequent allograft.
| Additional study of relevance
Recently ( 
| E XPERIMENTAL S ECONDARY ALLOTR ANS PL ANTATION AF TER XENO -S ENS ITIZ ATION IN CON CORDANT MODEL S
Although today clinical concordant xenotransplantation, that is, between closely-related species where hyperacute rejection would not be anticipated, for example, NHP-to-human, 3 is not being considered, there have been a few experimental studies of secondary allotransplantation in a NHP after an initial concordant xenograft that are of interest. Given the closer evolutionary relationship between the initial donor and recipient species, with the likelihood of more conserved antigen structure, it might be anticipated that there would be greater cross-reactivity of antibodies that develop after rejection of a concordant xenograft.
However, three groups provided evidence to suggest that primary concordant xenografts in immunosuppressed NHPs did not induce a humoral or an accelerated cell-mediated immune response that jeopardized the survival of a secondary allograft (Table 2) .
4,10,11
| ADDITIONAL S TUDIE S OF RELE VAN CE
There have also been studies in other animal models that provide further evidence.
The groups of Gannedahl et al, 12 Chice et al 13 and Di Stefano et al, 14 respectively, using initial mouse-to-Lewis rat, hamster-to Lewis rat and hamster-to Lewis rat models followed by allotransplantation, independently concluded that an initial xenograft was not detrimental to a subsequent allograft.
In contrast, two groups provided data to suggest that secondary allografts are at risk after transplantation into a recipient previously sensitized to a xenograft, although these studies were not in the clinically more relevant pig-to-NHP model.
Hammer et al 15 carried out allogeneic and xenogeneic heterotopic heart transplantation. Six dog recipients accepted primary allogeneic hearts (with immunosuppressive therapy in the form of cyclosporine, azathioprine, and corticosteroids) with a mean allograft survival of 18 days. Heart xenotransplants between donor foxes and recipient dogs (under identical immunosuppressive therapy) were rejected in a mean of 10 days, and subsequent dog allograft hearts (under the same immunosuppressive regimen) were rejected in a mean of 5 days.
Therefore, rejection of the concordant xenograft reduced survival of a subsequent allograft (from a mean of 18 days to 5 days).
In addition, Etheredge et al 16 reported accelerated skin allograft rejection following xenogeneic sensitization in dog-(a distantly related species) and guinea pig-(a closely related species) to-rabbit models. Five rabbit recipients accepted a primary allogeneic skin graft with a mean survival of 10 days. Fifteen rabbits received an allograft after being sensitized to a guinea pig skin xenograft, with TA B L E 2 Secondary allotransplantation after xeno-sensitization in concordant NHP models The baboon in which the xenograft survived 120 days received a secondary baboon heart allotransplant, which was followed for >30 days without features of rejection (until elective euthanasia). At the time of allotransplantation, a lymphocytotoxicity assay carried out with serum from the recipient and cells from the baboon heart donor was negative.
c Despite the fact that, after xenotransplantation, 50% of the baboons developed cytotoxic antibodies against the MHC class II-like antigens expressed by lymphocytes of more than half of a panel of 12 baboons, neither the presence of these antibodies nor the severity of the prior xenograft rejection impacted the histology of allograft rejection. When T-cell lines were developed from T cells isolated from xenograft biopsies, none demonstrated cell-mediated proliferative or cytotoxic activity against cells from the secondary allograft donor. These data suggested that a prior concordant xenograft was not detrimental to a subsequent allograft.
rejection occurring in a mean of 7 days. Eighteen rabbits received an allograft following a dog skin xenograft, with rejection in a mean of 7 days. It would therefore appear that, in these models, an initial skin xenograft (whether discordant or concordant) was detrimental to survival of a subsequent skin allograft.
| CLINIC AL ALLOTR ANS PL ANTATION AF TER (OR B EFORE) E XP OSURE TO PI G ANTI G EN S
Six clinical studies are of relevance. Three patients undergoing dialysis were exposed to pig kidneys that were inserted into the dialysis circuit, and there were three studies related to bridging a patient in hepatic failure to liver allotransplantation. In addition, there was one study in which patients with renal allografts were subsequently sensitized to pig antigens. (Table 3A) After a course of plasmapheresis to remove anti-pig antibodies, Welsh and his colleagues exposed a patient undergoing dialysis to WT pig kidneys on two occasions approximately one month apart. 17, 18 The patient received conventional immunosuppressive therapy to cover the "experimental period". The two pig kidneys were perfused for 6 and 1.5 hours, respectively. There was only a weak anti-pig immune response. The patient successfully underwent renal allotransplantation.
| Kidney allotransplantation after exposure to pig antigens
In 1996, Breimer, Rydberg, and colleagues [19] [20] [21] had to be removed 18 days later for persistent bleeding associated with thrombocytopenia which had been problematic for years, even before exposure to the pig kidney. 19 It therefore did not appear to be a complication of sensitization to the pig kidney. Microscopy showed features of cellular and vascular rejection.
Based on this, it can be concluded that the perfusion experiments were not detrimental to the patients in obtaining subsequent renal allografts, although there may be some doubt in the second patient. It should be borne in mind that a large number of passenger leukocytes are transferred from the organ to the recipient during ex vivo organ perfusion, 22 increasing the risk of immunization to pig antigens. (Table 3A) In 1994, Chari et al 23 reported successful liver allotransplantation in a patient who had undergone ex vivo perfusion of five pig livers during the previous few days, although no details were given on the anti-pig or anti-HLA antibody responses. however, there was a significant increase in anti-Gal IgG antibody, although no antibodies developed to non-Gal pig specificities. Although the periods of organ perfusion were short, livers contain large numbers of passenger leukocytes that enter the patient's circulation, increasing the possibility of sensitization.
| Liver allotransplantation after exposure to pig antigens
5.3 | Exposure to pig antigens after, or at the time of, kidney allotransplantation (Table 3B) There is one other clinical study of relevance. Groth and coworkers
26
reported on ten patients with type 1 diabetes with renal allografts who received WT fetal pig islet-like cell clusters intraportally or under the kidney capsule (Table 3B ). All patients developed xenoreactive antibodies against Gal antigens, which remained high for up to 6-8 years, 27 but there was no increase in panel-reactive antibodies, and the kidney grafts continued to function well. 28 
| CON CLUS IONS
The data from discordant experimental pig-to-NHP models of xenotransplantation indicated that a primary xenograft did not in- Table 4 ). The majority of groups have concluded that human anti-HLA antibodies can cross-react with SLA and thus jeopardize the survival of a pig graft. [30] [31] [32] A smaller number of groups, however, have found no evidence of cross-reactivity between antibodies directed to HLA and SLA (Table 4) .
If, indeed, HLA-specific antibodies do recognize SLA, then the question needs to be asked as to why no groups have reported a detrimental effect of initial exposure to SLA on the outcome of subsequent allotransplantation, as reviewed in the present report. HLA and SLA genes encode proteins on the cell surface (antigens), but the HLA genes are at least 100 kbp longer than SLA and are greater than SLA in number. 33 As the HLA system is more complex than the SLA system, the greater number and complexity of anti-HLA antibodies might result in their recognition of SLA. In contrast, anti-SLA antibodies may be insufficient in variety and number to recognize HLA.
This hypothesis requires investigation.
The results of our review must be interpreted cautiously as not only are the numbers of reports very few, and in some cases almost anecdotal, but exposure to pig antigens was at times relatively brief.
There were also varying periods between developing sensitization to pig antigens and subsequent exposure to alloantigens. With initial clinical trials of pig organ transplantation drawing closer, more data from the important pig-to-NHP model are required to allow a deeper understanding of the topic.
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TA B L E 4 Studies relating to cross-reactivity between the anti-HLA immune response and pig antigens to investigate whether HLA sensitization is detrimental to pig xenotransplantation Author/Year Ref.
HLA sensitization is detrimental
Naziruddin et al, 1998 30 Taylor et al, 1998 31 Barreau et al, 2000 35 Popma et al, 2000 36 Mulder et al, 2000 37 Oostingh et al, 2002 38 Varela et al, 2003 39 Mulder et al, 2010 42 Martens et al, 2017
32
HLA sensitization is not detrimental
Bartholomew et al, 1997 34 Wong et al, 2006 40 Hara et al, 2006 41 Zhang et al 
